JTV-519 (K201 free base) is a cardioprotective agent with antiarrhythmic properties; it acts as a Ca²⁺-dependent sarcoplasmic reticulum Ca²⁺-stimulated ATPase (SERCA) inhibitor and a partial agonist of ryanodine receptors in striated muscle; it improves cardiac function in murine models of polymicrobial sepsis induced by cecal ligation and puncture (CLP), significantly increasing ejection fraction (EF) and fractional shortening (FS).